Adapting preference-based utility measures to capture the impact of cancer treatment-related symptoms

It is important that patient-reported outcome (PRO) measures used to assess cancer therapies adequately capture the benefits and risks experienced by patients, particularly when adverse event profiles differ across therapies. This study explores the case for augmenting preference-based utility measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Koonal K., Bennett, Bryan, Lenny, Andrew, Longworth, Louise, Brazier, John E., Oppe, Mark, Pickard, A. Simon, Shaw, James W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526451/
https://www.ncbi.nlm.nih.gov/pubmed/34142266
http://dx.doi.org/10.1007/s10198-021-01337-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526451/
https://www.ncbi.nlm.nih.gov/pubmed/34142266
http://dx.doi.org/10.1007/s10198-021-01337-6

Ejemplares similares